# Effect of Live Combined Bifidobacterium,Lactobacillus and Enterococcus Capsules on Oral Mucositis in Nasopharyngeal Carcinoma Patients Receiving Radiotherapy.

> **NCT03112837** · NA · UNKNOWN · sponsor: **Jiangxi Provincial Cancer Hospital** · enrollment: 40 (estimated)

## Conditions studied

- Oral Mucositis
- Quality of Life

## Interventions

- **OTHER:** Lactobacillus, Bifidobacterium and Enterococcus

## Key facts

- **NCT ID:** NCT03112837
- **Lead sponsor:** Jiangxi Provincial Cancer Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-03-10
- **Primary completion:** 2018-01-05
- **Final completion:** 2018-01-05
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2017-12-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03112837

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03112837, "Effect of Live Combined Bifidobacterium,Lactobacillus and Enterococcus Capsules on Oral Mucositis in Nasopharyngeal Carcinoma Patients Receiving Radiotherapy.". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03112837. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*